Septerna (SEPN) News Today $28.36 +0.44 (+1.58%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$28.36 0.00 (-0.02%) As of 05/22/2026 06:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SEPN Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2026 April 2026 March 2026 February 2026 January 2026 December 2025 November 2025 October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 Time Period Party Time: Brokers Just Made Major Increases To Their Septerna, Inc. (NASDAQ:SEPN) Earnings ForecastsMay 17, 2026 | finance.yahoo.comSepterna (SEPN) Stock Forecast & Price TargetMay 15, 2026 | investing.comEarnings Update: Septerna, Inc. (NASDAQ:SEPN) Just Reported And Analysts Are Boosting Their EstimatesMay 15, 2026 | finance.yahoo.comQ2 Earnings Forecast for Septerna Issued By HC WainwrightMay 15, 2026 | marketbeat.comSepterna's (SEPN) "Buy" Rating Reaffirmed at HC WainwrightMay 14, 2026 | americanbankingnews.comSepterna (SEPN) Expected to Announce Earnings on ThursdayMay 14, 2026 | americanbankingnews.comSepterna Highlights Business Progress and Reports First Quarter 2026 Financial ResultsMay 11, 2026 | globenewswire.comHow Analyst Upgrade and Conference Spotlight Will Impact Septerna (SEPN) InvestorsMay 8, 2026 | finance.yahoo.comSepterna to Present at Bank of America Securities Health Care ConferenceMay 5, 2026 | globenewswire.comSepterna, Inc. ($SEPN) CEO 2025 Pay RevealedMay 1, 2026 | quiverquant.comQSepterna (NASDAQ:SEPN) Now Covered by Stifel NicolausMay 1, 2026 | marketbeat.comSepterna, Inc. (NASDAQ:SEPN) Sees Significant Growth in Short InterestMay 1, 2026 | marketbeat.comElizabeth Bhatt Sells 4,000 Shares of Septerna (NASDAQ:SEPN) StockApril 18, 2026 | insidertrades.comSepterna, Inc.: Septerna Announces Initiation of Phase 1 Clinical Trial of SEP-479, an Oral Small Molecule PTH1R Agonist for the Treatment of HypoparathyroidismApril 15, 2026 | finanznachrichten.deSepterna Begins Phase 1 Trial of Oral SEP-479April 13, 2026 | tipranks.comSepterna Announces Initiation of Phase 1 Clinical Trial of SEP-479, an Oral Small Molecule PTH1R Agonist for the Treatment of HypoparathyroidismApril 13, 2026 | globenewswire.comSepterna Rings the Nasdaq Stock Market Opening BellApril 3, 2026 | nasdaq.comSepterna (SEPN) price target increased by 34.39% to 46.41March 27, 2026 | msn.comAnalysts Conflicted on These Technology Names: Fortinet (FTNT), Septerna, Inc. (SEPN) and Oracle (ORCL)March 12, 2026 | theglobeandmail.comSepterna beats fourth quarter loss estimates on collaboration revenueMarch 10, 2026 | investing.comSepterna tops Q4 loss expectations as collaboration revenue lifts resultsMarch 10, 2026 | msn.comSepterna, Inc. Reports Positive Phase 1 Data for SEP-631 and Advances Pipeline Development PlansMarch 9, 2026 | quiverquant.comQSepterna Highlights Pipeline Progress and Reports Fourth Quarter and Full Year 2025 Financial ResultsMarch 9, 2026 | globenewswire.comSepterna (NASDAQ:SEPN) Insider Samira Shaikhly Sells 70,453 SharesMarch 5, 2026 | insidertrades.comDoes SEP-631’s Phase 1 Proof-of-Mechanism and 2026 Trial Plan Reshape Septerna’s Mast Cell Strategy (SEPN)?March 5, 2026 | finance.yahoo.comSepterna Advances SEP-631 After Positive Phase 1 ResultsMarch 2, 2026 | tipranks.comSepterna, Inc. Announces Positive Phase 1 Results for SEP-631, a Potential Treatment for Chronic Spontaneous Urticaria March 1, 2026 | quiverquant.comQSepterna Announces Positive Phase 1 Data for SEP-631, an Oral MRGPRX2 NAM for the Treatment of Mast Cell-Driven Diseases, and Outlines Initial Phase 2 Development StrategyMarch 1, 2026 | globenewswire.comSEP-631 Phase 1 Readout: The Catalyst Set To Drive Septerna In 2026February 25, 2026 | seekingalpha.comSepterna to Present at TD Cowen 46th Annual Health Care ConferenceFebruary 24, 2026 | globenewswire.comSepterna Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)February 10, 2026 | globenewswire.comSepterna to Present Data from Phase 1 Clinical Trial of SEP-631 for the Treatment of Mast Cell-Driven Diseases at 2026 AAAAI Annual MeetingFebruary 10, 2026 | globenewswire.comAssessing Septerna (SEPN) Valuation After Recent Share Price Pullback And One Year 40.63% ReturnJanuary 11, 2026 | finance.yahoo.comSepterna Appoints Mark Wilson as Chief Legal OfficerJanuary 8, 2026 | tipranks.comSepterna Expands Leadership with Appointment of Industry Veteran Mark A. Wilson as Chief Legal OfficerJanuary 8, 2026 | globenewswire.comSepterna initiated with a Buy at JonesResearchDecember 23, 2025 | msn.comJones Trading initiates coverage of Septerna (SEPN) with buy recommendationDecember 23, 2025 | msn.comSepterna initiated with a strong buy at Raymond JamesDecember 19, 2025 | msn.comRaymond James initiates coverage of Septerna (SEPN) with strong buy recommendationDecember 19, 2025 | msn.comSepterna to Present at 44th Annual J.P. Morgan Healthcare ConferenceDecember 17, 2025 | globenewswire.comTruist Securities initiates coverage of Septerna (SEPN) with buy recommendationDecember 16, 2025 | msn.comSepterna initiated with a buy at TruistDecember 15, 2025 | msn.comSepterna to Participate in 8th Annual Evercore Healthcare ConferenceNovember 25, 2025 | globenewswire.comSepterna's Novo Partnership Begins To Transform The StoryNovember 25, 2025 | seekingalpha.comSepterna price target raised to $34 from $28 at JPMorganNovember 18, 2025 | msn.comSepterna (SEPN) Price Target Increased by 20.29% to 28.22November 17, 2025 | msn.comWhy Septerna (SEPN) Is Up 28.5% After Posting a Surprise Profit and Analyst UpgradesNovember 17, 2025 | finance.yahoo.comA Look at Septerna (SEPN) Valuation Following Strong Q3 Sales and Swing to ProfitabilityNovember 15, 2025 | finance.yahoo.comSepterna stock surges after Wells Fargo upgradeNovember 15, 2025 | au.investing.comSepterna upgraded to Overweight from Equal Weight at Wells FargoNovember 15, 2025 | msn.com Get Septerna News Delivered to You Automatically Sign up to receive the latest news and ratings for SEPN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SEPN Media Mentions By Week SEPN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SEPN News Sentiment▼0.000.45▲Average Medical News Sentiment SEPN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SEPN Articles This Week▼13▲SEPN Articles Average Week Get the Latest News and Ratings for SEPN and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Septerna and its competitors. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies DNTH News Today CRSP News Today INDV News Today MANE News Today KNSA News Today NAMS News Today TVTX News Today CPRX News Today AMRX News Today CRNX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SEPN) was last updated on 5/23/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredThe AI stocks about to become worthless (and one that isn't)Louis Navellier - who manages $1.1 billion including $358 million in AI stocks - says a new AI computer being ...InvestorPlace | SponsoredSpaceX just filed. The clock is ticking.Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Septerna, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Septerna With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
